United Royale Holdings Corp.
United Royale Holdings Corp. (URYL) Stock Competitors & Peer Comparison
See (URYL) competitors and their performances in Stock Market.
Peer Comparison Table: Agricultural Farm Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| URYL | $0.00 | +0.00% | 15.1K | N/A | N/A | N/A |
| WLMIF | $2.94 | +0.00% | 18.4B | 12.78 | $0.23 | +3.72% |
| WLMIY | $29.53 | +1.65% | 17.7B | 12.56 | $2.26 | +3.86% |
| MHGVY | $21.78 | +0.83% | 11.4B | 11.35 | $1.90 | +2.85% |
| MNHVF | $21.22 | +2.27% | 11.2B | 11.17 | $1.90 | +2.91% |
| SALRY | $15.55 | +0.05% | 8.5B | 71.70 | $0.22 | +3.45% |
| SALRF | $55.50 | +0.00% | 7.5B | 61.67 | $0.90 | +3.92% |
| KLKBF | $6.17 | +0.00% | 6.8B | 11.43 | $0.54 | +2.41% |
| KLKBY | $5.50 | +0.00% | 6.1B | 25.00 | $0.22 | +2.71% |
| CPOUF | $0.70 | +0.00% | 5.3B | 7.00 | $0.10 | +5.53% |
Stock Comparison
URYL vs WLMIF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, WLMIF has a market cap of 18.4B. Regarding current trading prices, URYL is priced at $0.00, while WLMIF trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas WLMIF's P/E ratio is 12.78. In terms of profitability, URYL's ROE is -4.37%, compared to WLMIF's ROE of +0.04%. Regarding short-term risk, URYL is less volatile compared to WLMIF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check WLMIF's competition here
URYL vs WLMIY Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, WLMIY has a market cap of 17.7B. Regarding current trading prices, URYL is priced at $0.00, while WLMIY trades at $29.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas WLMIY's P/E ratio is 12.56. In terms of profitability, URYL's ROE is -4.37%, compared to WLMIY's ROE of +0.04%. Regarding short-term risk, URYL is less volatile compared to WLMIY. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check WLMIY's competition here
URYL vs MHGVY Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, MHGVY has a market cap of 11.4B. Regarding current trading prices, URYL is priced at $0.00, while MHGVY trades at $21.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas MHGVY's P/E ratio is 11.35. In terms of profitability, URYL's ROE is -4.37%, compared to MHGVY's ROE of +0.21%. Regarding short-term risk, URYL is less volatile compared to MHGVY. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check MHGVY's competition here
URYL vs MNHVF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, MNHVF has a market cap of 11.2B. Regarding current trading prices, URYL is priced at $0.00, while MNHVF trades at $21.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas MNHVF's P/E ratio is 11.17. In terms of profitability, URYL's ROE is -4.37%, compared to MNHVF's ROE of +0.21%. Regarding short-term risk, URYL and MNHVF have similar daily volatility (0.00).Check MNHVF's competition here
URYL vs SALRY Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, SALRY has a market cap of 8.5B. Regarding current trading prices, URYL is priced at $0.00, while SALRY trades at $15.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas SALRY's P/E ratio is 71.70. In terms of profitability, URYL's ROE is -4.37%, compared to SALRY's ROE of +0.06%. Regarding short-term risk, URYL is less volatile compared to SALRY. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check SALRY's competition here
URYL vs SALRF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, SALRF has a market cap of 7.5B. Regarding current trading prices, URYL is priced at $0.00, while SALRF trades at $55.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas SALRF's P/E ratio is 61.67. In terms of profitability, URYL's ROE is -4.37%, compared to SALRF's ROE of +0.06%. Regarding short-term risk, URYL is less volatile compared to SALRF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check SALRF's competition here
URYL vs KLKBF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, KLKBF has a market cap of 6.8B. Regarding current trading prices, URYL is priced at $0.00, while KLKBF trades at $6.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas KLKBF's P/E ratio is 11.43. In terms of profitability, URYL's ROE is -4.37%, compared to KLKBF's ROE of +0.08%. Regarding short-term risk, URYL and KLKBF have similar daily volatility (0.00).Check KLKBF's competition here
URYL vs KLKBY Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, KLKBY has a market cap of 6.1B. Regarding current trading prices, URYL is priced at $0.00, while KLKBY trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas KLKBY's P/E ratio is 25.00. In terms of profitability, URYL's ROE is -4.37%, compared to KLKBY's ROE of +0.08%. Regarding short-term risk, URYL is less volatile compared to KLKBY. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check KLKBY's competition here
URYL vs CPOUF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, CPOUF has a market cap of 5.3B. Regarding current trading prices, URYL is priced at $0.00, while CPOUF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas CPOUF's P/E ratio is 7.00. In terms of profitability, URYL's ROE is -4.37%, compared to CPOUF's ROE of +0.09%. Regarding short-term risk, URYL is less volatile compared to CPOUF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check CPOUF's competition here
URYL vs CHPFF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, CHPFF has a market cap of 4.6B. Regarding current trading prices, URYL is priced at $0.00, while CHPFF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas CHPFF's P/E ratio is 6.88. In terms of profitability, URYL's ROE is -4.37%, compared to CHPFF's ROE of +0.09%. Regarding short-term risk, URYL is less volatile compared to CHPFF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check CHPFF's competition here
URYL vs FSRCY Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, FSRCY has a market cap of 4.3B. Regarding current trading prices, URYL is priced at $0.00, while FSRCY trades at $252.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas FSRCY's P/E ratio is 12.26. In terms of profitability, URYL's ROE is -4.37%, compared to FSRCY's ROE of +0.15%. Regarding short-term risk, URYL and FSRCY have similar daily volatility (0.00).Check FSRCY's competition here
URYL vs PPOKF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, PPOKF has a market cap of 4B. Regarding current trading prices, URYL is priced at $0.00, while PPOKF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas PPOKF's P/E ratio is 12.25. In terms of profitability, URYL's ROE is -4.37%, compared to PPOKF's ROE of +0.20%. Regarding short-term risk, URYL is less volatile compared to PPOKF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check PPOKF's competition here
URYL vs FTROF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, FTROF has a market cap of 3.5B. Regarding current trading prices, URYL is priced at $0.00, while FTROF trades at $2.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas FTROF's P/E ratio is 9.83. In terms of profitability, URYL's ROE is -4.37%, compared to FTROF's ROE of +0.15%. Regarding short-term risk, URYL is less volatile compared to FTROF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check FTROF's competition here
URYL vs KNKZF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, KNKZF has a market cap of 3B. Regarding current trading prices, URYL is priced at $0.00, while KNKZF trades at $90.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas KNKZF's P/E ratio is 13.25. In terms of profitability, URYL's ROE is -4.37%, compared to KNKZF's ROE of +0.09%. Regarding short-term risk, URYL is less volatile compared to KNKZF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check KNKZF's competition here
URYL vs GARPY Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, GARPY has a market cap of 2.9B. Regarding current trading prices, URYL is priced at $0.00, while GARPY trades at $23.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas GARPY's P/E ratio is 7.36. In terms of profitability, URYL's ROE is -4.37%, compared to GARPY's ROE of +0.06%. Regarding short-term risk, URYL is less volatile compared to GARPY. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check GARPY's competition here
URYL vs BKFKF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, BKFKF has a market cap of 2.9B. Regarding current trading prices, URYL is priced at $0.00, while BKFKF trades at $48.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas BKFKF's P/E ratio is 34.89. In terms of profitability, URYL's ROE is -4.37%, compared to BKFKF's ROE of +0.05%. Regarding short-term risk, URYL and BKFKF have similar daily volatility (0.00).Check BKFKF's competition here
URYL vs GARPF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, GARPF has a market cap of 2.6B. Regarding current trading prices, URYL is priced at $0.00, while GARPF trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas GARPF's P/E ratio is 6.94. In terms of profitability, URYL's ROE is -4.37%, compared to GARPF's ROE of +0.06%. Regarding short-term risk, URYL is less volatile compared to GARPF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check GARPF's competition here
URYL vs UPBMF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, UPBMF has a market cap of 2.2B. Regarding current trading prices, URYL is priced at $0.00, while UPBMF trades at $3.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas UPBMF's P/E ratio is 14.03. In terms of profitability, URYL's ROE is -4.37%, compared to UPBMF's ROE of +0.29%. Regarding short-term risk, URYL is less volatile compared to UPBMF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check UPBMF's competition here
URYL vs ASTVF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, ASTVF has a market cap of 2.1B. Regarding current trading prices, URYL is priced at $0.00, while ASTVF trades at $10.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas ASTVF's P/E ratio is 21.14. In terms of profitability, URYL's ROE is -4.37%, compared to ASTVF's ROE of +0.06%. Regarding short-term risk, URYL is less volatile compared to ASTVF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check ASTVF's competition here
URYL vs SLCJY Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, SLCJY has a market cap of 1.7B. Regarding current trading prices, URYL is priced at $0.00, while SLCJY trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas SLCJY's P/E ratio is 25.88. In terms of profitability, URYL's ROE is -4.37%, compared to SLCJY's ROE of +0.06%. Regarding short-term risk, URYL is less volatile compared to SLCJY. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check SLCJY's competition here
URYL vs DNDPF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, DNDPF has a market cap of 1.3B. Regarding current trading prices, URYL is priced at $0.00, while DNDPF trades at $14.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas DNDPF's P/E ratio is -35.89. In terms of profitability, URYL's ROE is -4.37%, compared to DNDPF's ROE of -0.12%. Regarding short-term risk, URYL and DNDPF have similar daily volatility (0.00).Check DNDPF's competition here
URYL vs MHPSY Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, MHPSY has a market cap of 1.1B. Regarding current trading prices, URYL is priced at $0.00, while MHPSY trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas MHPSY's P/E ratio is 6.12. In terms of profitability, URYL's ROE is -4.37%, compared to MHPSY's ROE of +0.08%. Regarding short-term risk, URYL and MHPSY have similar daily volatility (0.00).Check MHPSY's competition here
URYL vs CTTQF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, CTTQF has a market cap of 985.2M. Regarding current trading prices, URYL is priced at $0.00, while CTTQF trades at $2.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas CTTQF's P/E ratio is 70.67. In terms of profitability, URYL's ROE is -4.37%, compared to CTTQF's ROE of +0.04%. Regarding short-term risk, URYL and CTTQF have similar daily volatility (0.00).Check CTTQF's competition here
URYL vs AEPLF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, AEPLF has a market cap of 974.7M. Regarding current trading prices, URYL is priced at $0.00, while AEPLF trades at $25.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas AEPLF's P/E ratio is 10.98. In terms of profitability, URYL's ROE is -4.37%, compared to AEPLF's ROE of +0.16%. Regarding short-term risk, URYL is less volatile compared to AEPLF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check AEPLF's competition here
URYL vs GRGSF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, GRGSF has a market cap of 894.6M. Regarding current trading prices, URYL is priced at $0.00, while GRGSF trades at $7.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas GRGSF's P/E ratio is -66.42. In terms of profitability, URYL's ROE is -4.37%, compared to GRGSF's ROE of -0.10%. Regarding short-term risk, URYL and GRGSF have similar daily volatility (0.00).Check GRGSF's competition here
URYL vs AAGRY Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, AAGRY has a market cap of 885.4M. Regarding current trading prices, URYL is priced at $0.00, while AAGRY trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas AAGRY's P/E ratio is 10.00. In terms of profitability, URYL's ROE is -4.37%, compared to AAGRY's ROE of +0.07%. Regarding short-term risk, URYL and AAGRY have similar daily volatility (0.00).Check AAGRY's competition here
URYL vs MRVSY Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, MRVSY has a market cap of 826.5M. Regarding current trading prices, URYL is priced at $0.00, while MRVSY trades at $3.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas MRVSY's P/E ratio is 9.05. In terms of profitability, URYL's ROE is -4.37%, compared to MRVSY's ROE of +0.54%. Regarding short-term risk, URYL is less volatile compared to MRVSY. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check MRVSY's competition here
URYL vs GRCLF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, GRCLF has a market cap of 780.5M. Regarding current trading prices, URYL is priced at $0.00, while GRCLF trades at $3.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas GRCLF's P/E ratio is 27.08. In terms of profitability, URYL's ROE is -4.37%, compared to GRCLF's ROE of -0.01%. Regarding short-term risk, URYL and GRCLF have similar daily volatility (0.00).Check GRCLF's competition here
URYL vs EDESY Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, EDESY has a market cap of 729.1M. Regarding current trading prices, URYL is priced at $0.00, while EDESY trades at $19.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas EDESY's P/E ratio is 15.18. In terms of profitability, URYL's ROE is -4.37%, compared to EDESY's ROE of +0.05%. Regarding short-term risk, URYL is less volatile compared to EDESY. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check EDESY's competition here
URYL vs PTABF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, PTABF has a market cap of 692.9M. Regarding current trading prices, URYL is priced at $0.00, while PTABF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas PTABF's P/E ratio is 9.00. In terms of profitability, URYL's ROE is -4.37%, compared to PTABF's ROE of +0.07%. Regarding short-term risk, URYL is less volatile compared to PTABF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check PTABF's competition here
URYL vs PPLFY Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, PPLFY has a market cap of 660.2M. Regarding current trading prices, URYL is priced at $0.00, while PPLFY trades at $4.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas PPLFY's P/E ratio is 6.13. In terms of profitability, URYL's ROE is -4.37%, compared to PPLFY's ROE of +0.14%. Regarding short-term risk, URYL is less volatile compared to PPLFY. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check PPLFY's competition here
URYL vs PPLFF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, PPLFF has a market cap of 585.7M. Regarding current trading prices, URYL is priced at $0.00, while PPLFF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas PPLFF's P/E ratio is 4.29. In terms of profitability, URYL's ROE is -4.37%, compared to PPLFF's ROE of +0.14%. Regarding short-term risk, URYL is less volatile compared to PPLFF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check PPLFF's competition here
URYL vs ORENF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, ORENF has a market cap of 583.1M. Regarding current trading prices, URYL is priced at $0.00, while ORENF trades at $5.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas ORENF's P/E ratio is 12.33. In terms of profitability, URYL's ROE is -4.37%, compared to ORENF's ROE of +0.09%. Regarding short-term risk, URYL is less volatile compared to ORENF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check ORENF's competition here
URYL vs ASAGF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, ASAGF has a market cap of 572.6M. Regarding current trading prices, URYL is priced at $0.00, while ASAGF trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas ASAGF's P/E ratio is 13.57. In terms of profitability, URYL's ROE is -4.37%, compared to ASAGF's ROE of +0.04%. Regarding short-term risk, URYL and ASAGF have similar daily volatility (0.00).Check ASAGF's competition here
URYL vs SISAF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, SISAF has a market cap of 564.3M. Regarding current trading prices, URYL is priced at $0.00, while SISAF trades at $54.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas SISAF's P/E ratio is 4.93. In terms of profitability, URYL's ROE is -4.37%, compared to SISAF's ROE of +0.13%. Regarding short-term risk, URYL is less volatile compared to SISAF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check SISAF's competition here
URYL vs AAYYY Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, AAYYY has a market cap of 554.5M. Regarding current trading prices, URYL is priced at $0.00, while AAYYY trades at $9.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas AAYYY's P/E ratio is 13.53. In terms of profitability, URYL's ROE is -4.37%, compared to AAYYY's ROE of +0.04%. Regarding short-term risk, URYL is less volatile compared to AAYYY. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check AAYYY's competition here
URYL vs UVPOF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, UVPOF has a market cap of 497.3M. Regarding current trading prices, URYL is priced at $0.00, while UVPOF trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas UVPOF's P/E ratio is 13.22. In terms of profitability, URYL's ROE is -4.37%, compared to UVPOF's ROE of +0.33%. Regarding short-term risk, URYL and UVPOF have similar daily volatility (0.00).Check UVPOF's competition here
URYL vs BRCPF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, BRCPF has a market cap of 441.1M. Regarding current trading prices, URYL is priced at $0.00, while BRCPF trades at $4.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas BRCPF's P/E ratio is 11.31. In terms of profitability, URYL's ROE is -4.37%, compared to BRCPF's ROE of -0.01%. Regarding short-term risk, URYL and BRCPF have similar daily volatility (0.00).Check BRCPF's competition here
URYL vs SLMCF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, SLMCF has a market cap of 429.2M. Regarding current trading prices, URYL is priced at $0.00, while SLMCF trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas SLMCF's P/E ratio is 22.00. In terms of profitability, URYL's ROE is -4.37%, compared to SLMCF's ROE of -0.03%. Regarding short-term risk, URYL and SLMCF have similar daily volatility (0.00).Check SLMCF's competition here
URYL vs SARDY Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, SARDY has a market cap of 350.6M. Regarding current trading prices, URYL is priced at $0.00, while SARDY trades at $18.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas SARDY's P/E ratio is 9.28. In terms of profitability, URYL's ROE is -4.37%, compared to SARDY's ROE of +0.10%. Regarding short-term risk, URYL is less volatile compared to SARDY. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check SARDY's competition here
URYL vs SLCJF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, SLCJF has a market cap of 339.6M. Regarding current trading prices, URYL is priced at $0.00, while SLCJF trades at $2.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas SLCJF's P/E ratio is 7.82. In terms of profitability, URYL's ROE is -4.37%, compared to SLCJF's ROE of +0.10%. Regarding short-term risk, URYL and SLCJF have similar daily volatility (0.00).Check SLCJF's competition here
URYL vs ALFDF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, ALFDF has a market cap of 284.7M. Regarding current trading prices, URYL is priced at $0.00, while ALFDF trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas ALFDF's P/E ratio is 9.35. In terms of profitability, URYL's ROE is -4.37%, compared to ALFDF's ROE of +0.17%. Regarding short-term risk, URYL and ALFDF have similar daily volatility (0.00).Check ALFDF's competition here
URYL vs SPZI Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, SPZI has a market cap of 273.9M. Regarding current trading prices, URYL is priced at $0.00, while SPZI trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas SPZI's P/E ratio is -43.00. In terms of profitability, URYL's ROE is -4.37%, compared to SPZI's ROE of N/A. Regarding short-term risk, URYL is less volatile compared to SPZI. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check SPZI's competition here
URYL vs SARDF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, SARDF has a market cap of 259.9M. Regarding current trading prices, URYL is priced at $0.00, while SARDF trades at $2.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas SARDF's P/E ratio is 7.13. In terms of profitability, URYL's ROE is -4.37%, compared to SARDF's ROE of +0.09%. Regarding short-term risk, URYL is less volatile compared to SARDF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check SARDF's competition here
URYL vs DDEJF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, DDEJF has a market cap of 240.7M. Regarding current trading prices, URYL is priced at $0.00, while DDEJF trades at $2.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas DDEJF's P/E ratio is 1.29. In terms of profitability, URYL's ROE is -4.37%, compared to DDEJF's ROE of +0.59%. Regarding short-term risk, URYL is less volatile compared to DDEJF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check DDEJF's competition here
URYL vs CAIHF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, CAIHF has a market cap of 217.4M. Regarding current trading prices, URYL is priced at $0.00, while CAIHF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas CAIHF's P/E ratio is 2.80. In terms of profitability, URYL's ROE is -4.37%, compared to CAIHF's ROE of +0.11%. Regarding short-term risk, URYL is less volatile compared to CAIHF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check CAIHF's competition here
URYL vs STNT Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, STNT has a market cap of 162.5M. Regarding current trading prices, URYL is priced at $0.00, while STNT trades at $6.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas STNT's P/E ratio is N/A. In terms of profitability, URYL's ROE is -4.37%, compared to STNT's ROE of +0.24%. Regarding short-term risk, URYL is less volatile compared to STNT. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check STNT's competition here
URYL vs DNDEF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, DNDEF has a market cap of 79.2M. Regarding current trading prices, URYL is priced at $0.00, while DNDEF trades at $15.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas DNDEF's P/E ratio is -38.66. In terms of profitability, URYL's ROE is -4.37%, compared to DNDEF's ROE of -0.12%. Regarding short-term risk, URYL is less volatile compared to DNDEF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check DNDEF's competition here
URYL vs NNUTU Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, NNUTU has a market cap of 41.6M. Regarding current trading prices, URYL is priced at $0.00, while NNUTU trades at $3,750.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas NNUTU's P/E ratio is 28.31. In terms of profitability, URYL's ROE is -4.37%, compared to NNUTU's ROE of N/A. Regarding short-term risk, URYL and NNUTU have similar daily volatility (0.00).Check NNUTU's competition here
URYL vs IDBHF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, IDBHF has a market cap of 30M. Regarding current trading prices, URYL is priced at $0.00, while IDBHF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas IDBHF's P/E ratio is 0.14. In terms of profitability, URYL's ROE is -4.37%, compared to IDBHF's ROE of +0.08%. Regarding short-term risk, URYL is less volatile compared to IDBHF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check IDBHF's competition here
URYL vs OPTHF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, OPTHF has a market cap of 23.2M. Regarding current trading prices, URYL is priced at $0.00, while OPTHF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas OPTHF's P/E ratio is -6.00. In terms of profitability, URYL's ROE is -4.37%, compared to OPTHF's ROE of -0.57%. Regarding short-term risk, URYL is less volatile compared to OPTHF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check OPTHF's competition here
URYL vs CTUNF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, CTUNF has a market cap of 18.5M. Regarding current trading prices, URYL is priced at $0.00, while CTUNF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas CTUNF's P/E ratio is -0.57. In terms of profitability, URYL's ROE is -4.37%, compared to CTUNF's ROE of -0.45%. Regarding short-term risk, URYL is less volatile compared to CTUNF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check CTUNF's competition here
URYL vs CLAD Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, CLAD has a market cap of 15M. Regarding current trading prices, URYL is priced at $0.00, while CLAD trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas CLAD's P/E ratio is -33.67. In terms of profitability, URYL's ROE is -4.37%, compared to CLAD's ROE of +0.04%. Regarding short-term risk, URYL is less volatile compared to CLAD. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check CLAD's competition here
URYL vs CMGHY Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, CMGHY has a market cap of 14.6M. Regarding current trading prices, URYL is priced at $0.00, while CMGHY trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas CMGHY's P/E ratio is -8.84. In terms of profitability, URYL's ROE is -4.37%, compared to CMGHY's ROE of -0.08%. Regarding short-term risk, URYL is less volatile compared to CMGHY. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check CMGHY's competition here
URYL vs PRCF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, PRCF has a market cap of 12M. Regarding current trading prices, URYL is priced at $0.00, while PRCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas PRCF's P/E ratio is N/A. In terms of profitability, URYL's ROE is -4.37%, compared to PRCF's ROE of N/A. Regarding short-term risk, URYL is less volatile compared to PRCF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check PRCF's competition here
URYL vs AASZF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, AASZF has a market cap of 8.4M. Regarding current trading prices, URYL is priced at $0.00, while AASZF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas AASZF's P/E ratio is -0.04. In terms of profitability, URYL's ROE is -4.37%, compared to AASZF's ROE of -0.80%. Regarding short-term risk, URYL is less volatile compared to AASZF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check AASZF's competition here
URYL vs PEASF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, PEASF has a market cap of 7.1M. Regarding current trading prices, URYL is priced at $0.00, while PEASF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas PEASF's P/E ratio is -1.56. In terms of profitability, URYL's ROE is -4.37%, compared to PEASF's ROE of -1.02%. Regarding short-term risk, URYL and PEASF have similar daily volatility (0.00).Check PEASF's competition here
URYL vs IGPFF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, IGPFF has a market cap of 5.4M. Regarding current trading prices, URYL is priced at $0.00, while IGPFF trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas IGPFF's P/E ratio is 35.35. In terms of profitability, URYL's ROE is -4.37%, compared to IGPFF's ROE of -0.39%. Regarding short-term risk, URYL is less volatile compared to IGPFF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check IGPFF's competition here
URYL vs MGNC Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, MGNC has a market cap of 5.3M. Regarding current trading prices, URYL is priced at $0.00, while MGNC trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas MGNC's P/E ratio is -21.25. In terms of profitability, URYL's ROE is -4.37%, compared to MGNC's ROE of -0.80%. Regarding short-term risk, URYL and MGNC have similar daily volatility (0.00).Check MGNC's competition here
URYL vs HERB Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, HERB has a market cap of 4.9M. Regarding current trading prices, URYL is priced at $0.00, while HERB trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas HERB's P/E ratio is 0.03. In terms of profitability, URYL's ROE is -4.37%, compared to HERB's ROE of +0.03%. Regarding short-term risk, URYL is less volatile compared to HERB. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check HERB's competition here
URYL vs GCEH Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, GCEH has a market cap of 1.8M. Regarding current trading prices, URYL is priced at $0.00, while GCEH trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas GCEH's P/E ratio is 0.02. In terms of profitability, URYL's ROE is -4.37%, compared to GCEH's ROE of +3.01%. Regarding short-term risk, URYL is less volatile compared to GCEH. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check GCEH's competition here
URYL vs CMGHF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, CMGHF has a market cap of 1.7M. Regarding current trading prices, URYL is priced at $0.00, while CMGHF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas CMGHF's P/E ratio is -0.50. In terms of profitability, URYL's ROE is -4.37%, compared to CMGHF's ROE of -0.10%. Regarding short-term risk, URYL and CMGHF have similar daily volatility (0.00).Check CMGHF's competition here
URYL vs GSFD Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, GSFD has a market cap of 1M. Regarding current trading prices, URYL is priced at $0.00, while GSFD trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas GSFD's P/E ratio is -0.16. In terms of profitability, URYL's ROE is -4.37%, compared to GSFD's ROE of -0.05%. Regarding short-term risk, URYL is less volatile compared to GSFD. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check GSFD's competition here
URYL vs PNDHF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, PNDHF has a market cap of 684.7K. Regarding current trading prices, URYL is priced at $0.00, while PNDHF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas PNDHF's P/E ratio is -0.20. In terms of profitability, URYL's ROE is -4.37%, compared to PNDHF's ROE of +0.27%. Regarding short-term risk, URYL is less volatile compared to PNDHF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check PNDHF's competition here
URYL vs FLAF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, FLAF has a market cap of 460.4K. Regarding current trading prices, URYL is priced at $0.00, while FLAF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas FLAF's P/E ratio is -0.01. In terms of profitability, URYL's ROE is -4.37%, compared to FLAF's ROE of -4.06%. Regarding short-term risk, URYL and FLAF have similar daily volatility (0.00).Check FLAF's competition here
URYL vs MSRM Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, MSRM has a market cap of 256.9K. Regarding current trading prices, URYL is priced at $0.00, while MSRM trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas MSRM's P/E ratio is -1.53. In terms of profitability, URYL's ROE is -4.37%, compared to MSRM's ROE of +2.80%. Regarding short-term risk, URYL is less volatile compared to MSRM. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check MSRM's competition here
URYL vs MSAH Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, MSAH has a market cap of 241.2K. Regarding current trading prices, URYL is priced at $0.00, while MSAH trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas MSAH's P/E ratio is 0.17. In terms of profitability, URYL's ROE is -4.37%, compared to MSAH's ROE of +0.38%. Regarding short-term risk, URYL is less volatile compared to MSAH. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check MSAH's competition here
URYL vs RSSFF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, RSSFF has a market cap of 170.3K. Regarding current trading prices, URYL is priced at $0.00, while RSSFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas RSSFF's P/E ratio is -0.18. In terms of profitability, URYL's ROE is -4.37%, compared to RSSFF's ROE of +1.23%. Regarding short-term risk, URYL is less volatile compared to RSSFF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check RSSFF's competition here
URYL vs SHMP Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, SHMP has a market cap of 127.8K. Regarding current trading prices, URYL is priced at $0.00, while SHMP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas SHMP's P/E ratio is -0.01. In terms of profitability, URYL's ROE is -4.37%, compared to SHMP's ROE of +0.78%. Regarding short-term risk, URYL and SHMP have similar daily volatility (0.00).Check SHMP's competition here
URYL vs HERF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, HERF has a market cap of 126.7K. Regarding current trading prices, URYL is priced at $0.00, while HERF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas HERF's P/E ratio is N/A. In terms of profitability, URYL's ROE is -4.37%, compared to HERF's ROE of +0.00%. Regarding short-term risk, URYL and HERF have similar daily volatility (0.00).Check HERF's competition here
URYL vs FLLLF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, FLLLF has a market cap of 94.3K. Regarding current trading prices, URYL is priced at $0.00, while FLLLF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas FLLLF's P/E ratio is -0.51. In terms of profitability, URYL's ROE is -4.37%, compared to FLLLF's ROE of +0.23%. Regarding short-term risk, URYL is less volatile compared to FLLLF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check FLLLF's competition here
URYL vs CHYI Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, CHYI has a market cap of 68.6K. Regarding current trading prices, URYL is priced at $0.00, while CHYI trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas CHYI's P/E ratio is -1.00. In terms of profitability, URYL's ROE is -4.37%, compared to CHYI's ROE of +14.52%. Regarding short-term risk, URYL is less volatile compared to CHYI. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check CHYI's competition here
URYL vs STEV Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, STEV has a market cap of 56.9K. Regarding current trading prices, URYL is priced at $0.00, while STEV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas STEV's P/E ratio is -0.01. In terms of profitability, URYL's ROE is -4.37%, compared to STEV's ROE of +0.02%. Regarding short-term risk, URYL and STEV have similar daily volatility (0.00).Check STEV's competition here
URYL vs SUWN Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, SUWN has a market cap of 20K. Regarding current trading prices, URYL is priced at $0.00, while SUWN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas SUWN's P/E ratio is -0.00. In terms of profitability, URYL's ROE is -4.37%, compared to SUWN's ROE of -0.49%. Regarding short-term risk, URYL and SUWN have similar daily volatility (0.00).Check SUWN's competition here
URYL vs SIAF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, SIAF has a market cap of 18.1K. Regarding current trading prices, URYL is priced at $0.00, while SIAF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas SIAF's P/E ratio is -0.00. In terms of profitability, URYL's ROE is -4.37%, compared to SIAF's ROE of -0.23%. Regarding short-term risk, URYL and SIAF have similar daily volatility (0.00).Check SIAF's competition here
URYL vs OGAA Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, OGAA has a market cap of 9.3K. Regarding current trading prices, URYL is priced at $0.00, while OGAA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas OGAA's P/E ratio is -0.01. In terms of profitability, URYL's ROE is -4.37%, compared to OGAA's ROE of -2.82%. Regarding short-term risk, URYL and OGAA have similar daily volatility (0.00).Check OGAA's competition here
URYL vs HLKKF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, HLKKF has a market cap of 8.7K. Regarding current trading prices, URYL is priced at $0.00, while HLKKF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas HLKKF's P/E ratio is N/A. In terms of profitability, URYL's ROE is -4.37%, compared to HLKKF's ROE of -10.09%. Regarding short-term risk, URYL is less volatile compared to HLKKF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check HLKKF's competition here
URYL vs TAER Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, TAER has a market cap of 5.7K. Regarding current trading prices, URYL is priced at $0.00, while TAER trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas TAER's P/E ratio is -0.02. In terms of profitability, URYL's ROE is -4.37%, compared to TAER's ROE of +0.44%. Regarding short-term risk, URYL is less volatile compared to TAER. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check TAER's competition here
URYL vs FFRMF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, FFRMF has a market cap of 1.7K. Regarding current trading prices, URYL is priced at $0.00, while FFRMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas FFRMF's P/E ratio is N/A. In terms of profitability, URYL's ROE is -4.37%, compared to FFRMF's ROE of -2.83%. Regarding short-term risk, URYL is less volatile compared to FFRMF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check FFRMF's competition here
URYL vs BIQIF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, BIQIF has a market cap of 1K. Regarding current trading prices, URYL is priced at $0.00, while BIQIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas BIQIF's P/E ratio is N/A. In terms of profitability, URYL's ROE is -4.37%, compared to BIQIF's ROE of +0.01%. Regarding short-term risk, URYL is less volatile compared to BIQIF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check BIQIF's competition here
URYL vs GLGLF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, GLGLF has a market cap of 384. Regarding current trading prices, URYL is priced at $0.00, while GLGLF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas GLGLF's P/E ratio is N/A. In terms of profitability, URYL's ROE is -4.37%, compared to GLGLF's ROE of -0.11%. Regarding short-term risk, URYL is less volatile compared to GLGLF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check GLGLF's competition here
URYL vs URBF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, URBF has a market cap of 250. Regarding current trading prices, URYL is priced at $0.00, while URBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas URBF's P/E ratio is N/A. In terms of profitability, URYL's ROE is -4.37%, compared to URBF's ROE of -56.17%. Regarding short-term risk, URYL is less volatile compared to URBF. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check URBF's competition here
URYL vs CFPI Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, CFPI has a market cap of 192. Regarding current trading prices, URYL is priced at $0.00, while CFPI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas CFPI's P/E ratio is N/A. In terms of profitability, URYL's ROE is -4.37%, compared to CFPI's ROE of +0.03%. Regarding short-term risk, URYL and CFPI have similar daily volatility (0.00).Check CFPI's competition here
URYL vs KALRQ Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, KALRQ has a market cap of 92. Regarding current trading prices, URYL is priced at $0.00, while KALRQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas KALRQ's P/E ratio is N/A. In terms of profitability, URYL's ROE is -4.37%, compared to KALRQ's ROE of -0.19%. Regarding short-term risk, URYL and KALRQ have similar daily volatility (0.00).Check KALRQ's competition here
URYL vs OCESP Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, OCESP has a market cap of 0. Regarding current trading prices, URYL is priced at $0.00, while OCESP trades at $16.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas OCESP's P/E ratio is N/A. In terms of profitability, URYL's ROE is -4.37%, compared to OCESP's ROE of N/A. Regarding short-term risk, URYL and OCESP have similar daily volatility (0.00).Check OCESP's competition here
URYL vs TSLLF Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, TSLLF has a market cap of 0. Regarding current trading prices, URYL is priced at $0.00, while TSLLF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas TSLLF's P/E ratio is 19.15. In terms of profitability, URYL's ROE is -4.37%, compared to TSLLF's ROE of N/A. Regarding short-term risk, URYL and TSLLF have similar daily volatility (0.00).Check TSLLF's competition here
URYL vs CAOX Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, CAOX has a market cap of 0. Regarding current trading prices, URYL is priced at $0.00, while CAOX trades at $420.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas CAOX's P/E ratio is N/A. In terms of profitability, URYL's ROE is -4.37%, compared to CAOX's ROE of N/A. Regarding short-term risk, URYL is less volatile compared to CAOX. This indicates potentially lower risk in terms of short-term price fluctuations for URYL.Check CAOX's competition here
URYL vs BYIN Comparison May 2026
URYL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, URYL stands at 15.1K. In comparison, BYIN has a market cap of 0. Regarding current trading prices, URYL is priced at $0.00, while BYIN trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
URYL currently has a P/E ratio of N/A, whereas BYIN's P/E ratio is N/A. In terms of profitability, URYL's ROE is -4.37%, compared to BYIN's ROE of +0.32%. Regarding short-term risk, URYL and BYIN have similar daily volatility (0.00).Check BYIN's competition here